A phase II clinical study of mAMSA in small cell carcinoma of the lung
Data up to Jan 2025
Total Citations Per Year
Abstract
References (7)
The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series
1974 • 155 citations
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
1980 • 81 citations
The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats.
1977 • 50 citations
Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.
1978 • 41 citations
Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.
1979 • 27 citations
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.
1979 • 21 citations
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
1980 • 11 citations